help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 27, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-0228
A more recent version of this article appeared on December 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/12/6418    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tong, P. C.
Right arrow Articles by Chan, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tong, P. C.
Right arrow Articles by Chan, J. C.

Submitted on February 3, 2005
Accepted on September 15, 2005

Association Of Testosterone, Insulin-Like Growth Factor-1 And C-Reactive Protein With Metabolic Syndrome In Chinese Middle-Aged Men With A Family History Of Type 2 Diabetes

Peter CY Tong*, Chung-Shun Ho, Vincent TF Yeung, Maggie CY Ng, Wing-Yee So, Risa Ozaki, Gary TC Ko, Ronald CW Ma, Emily Poon, Norman N Chan, Christopher WK Lam, and Juliana CN Chan

Department of Medicine and Therapeutics, Department of Chemical Pathology, Qualigenics Diabetes Centre, Postgraduate Education Centre, School of Public Health, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin; Our Lady of Maryknoll Hospital; Wong Tai Sin; Alice Ho Nethersole Hospital, Tai Po, Hong Kong and Howard Hughes Research Institute, University of Chicago, USA

* To whom correspondence should be addressed. E-mail: ptong{at}cuhk.edu.hk.

Context: Age-related declines in testosterone and insulin-growth factor (IGF-1) are associated with deposition of visceral fat, a component of the metabolic syndrome (MES).

Objective: Testosterone and IGF-1 may interact with familial disposition to diabetes mellitus to increase the association with MES.

Design: A cross-sectional cohort study

Setting: A university teaching hospital

Subjects: 179 middle-aged men with a family history of diabetes (FH) [aged 39.1 ± 8.1 yr] and 128 men without FH [aged 43.8 ± 8.5 yr].

Main Outcome Measures: Clinical characteristics, frequency of MES using the WHO criteria with Asian definitions of obesity (BMI ≥ 25 kg/m2), serum levels of total testosterone, IGF-1 and high-sensitive C-Reactive Protein (hs-CRP).

Results: Men with FH had higher frequency of MES than those without FH [39.1% vs. 23.4% (P = 0.004)]. On multivariate analysis, smoking (ex and current), low total testosterone and IGF-1 but elevated hs-CRP levels explained 35% of the MES variance in men with FH, The frequency of MES increased with declining tertiles of total testosterone and IGF-1 but increasing tertiles of hs-CRP. After adjustment for age and smoking history, subjects with all three risk factors had a 13-fold increase in risk association with MES than those without hormonal and inflammatory risk factors. These risk associations were not found in men without FH in whom only smoking (ex and current) and low total testosterone level were independent predictors for MES which explained 14% of the variance.

Conclusions: Clustering of a family history of diabetes, hormonal abnormalities and high hs-CRP is associated with MES in Chinese middle-aged men.


Key words: testosterone • insulin-like growth factor-1 • C-reactive protein • family history of diabetes • Chinese • middle-aged men • metabolic syndrome




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Kucic, I. B. Copland, J. Cuerquis, D. L. Coutu, L. E. Chalifour, R. F. Gagnon, and J. Galipeau
Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemia
Am J Physiol Renal Physiol, August 1, 2008; 295(2): F488 - F496.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society